Mechanisms of Beta Cell Function in Health and Disease

$32,760R01FY2015DKNIH

Indiana University Indianapolis, Indianapolis IN

Investigators

Linked publications & trials

Paper 39120544 Paper 38768367 Paper 38766166 Paper 38582818 Paper 38562689 Paper 38383396 Paper 38039846 Paper 37537395 Paper 37398133 Paper 36913741 Paper 36546354 Paper 35994083 Paper 35873174 Paper 35767947 Paper 35521759 Paper 34801552 Paper 34670785 Paper 34642772 Paper 34496231 Paper 34417862 Paper 34244696 Paper 34000022 Paper 33523973 Paper 33207244 Paper 32820009 Paper 32736653 Paper 32618633 Paper 32476252 Paper 32283079 Paper 31928885 Paper 31775218 Paper 31569518 Paper 31442418 Paper 31408375 Paper 31232620 Paper 31167894 Paper 31092479 Paper 31089753 Paper 31010952 Paper 30891858 Paper 30767048 Paper 30629603 Paper 30530850 Paper 30420428 Paper 30259209 Paper 30131394 Paper 30112687 Paper 30089716 Paper 30073765 Paper 29916386 Paper 29712667 Paper 29171129 Paper 29092051 Paper 28860125 Paper 28630491 Paper 28534310 Paper 28405880 Paper 28336465 Paper 28280903 Paper 28202550 Paper 28190264 Paper 27905899 Paper 27541297 Paper 27489309 Paper 27385327 Paper 27254268 Paper 26995649 Paper 26963742 Paper 26658005 Paper 26471901 Paper 26397425 Paper 26086963 Paper 25995453 Paper 25628460 Paper 25506600 Paper 25483958 Paper 25412163 Paper 25271154 Paper 24834975 Paper 24781246 Paper 24686036 Paper 24686035 Paper 24662515 Paper 24657667 Paper 24519994 Paper 24518186 Paper 24416262 Paper 24355258 Paper 24169046 Paper 24003933 Paper 23897951 Paper 23760565 Paper 23613561 Paper 23562090 Paper 22970344 Paper 22784847 Paper 22442300 Paper 22240811

Abstract

DESCRIPTION (provided by applicant): Emerging physiologic and genetic data suggest that dysfunction of the pancreatic beta cell is the key determinant of whether an insulin resistant individual will progress to frank hyperglycemia and diabetes. The long-range goal of this applicant is to define the pathways that govern beta cell function and survival in states of health in order to understand how these regulatory circuits are impaired in the pathologic state of Type 2 diabetes mellitus. The sarco-endoplasmic reticulum calcium ATPase or SERCA pump resides in the endoplasmic reticulum membrane and is responsible for maintaining a steep calcium concentration gradient between the cytosol and endoplasmic reticulum. In the beta cell, this gradient plays a key role in regulated insulin secretion and the maintenance of endoplasmic reticulum health and function. Preliminary and published work has revealed that expression of the predominant beta cell isoform, SERCA2, is markedly downregulated in rodent and human models of Type 2 diabetes mellitus. Furthermore, loss of SERCA2 expression leads to profound changes in beta cell secretory function and intracellular calcium flux in response to glucose. Given this background, the overall hypothesis of this proposal is that dysregulation of SERCA2 activity and expression is a key contributor to the beta cell dysfunction and death observed in Type 2 diabetes mellitus. To test this hypothesis, three aims are proposed. Aim 1: elucidate the in vivo role of SERCA2 in beta cell function using two novel mouse models of SERCA2 deficiency. Aim 2: delineate the transcriptional pathways that regulate SERCA2 expression in the pancreatic beta cell under normal conditions and in diabetes. Aim 3: elucidate the contribution of microRNAs in disruption of the SERCA2 gene regulatory network. The successful completion of these aims will precisely define the role of islet beta cell SERCA2 in metabolic and glucose homeostasis and identify the pathways that lead to its transcriptional dysregulation in Type 2 diabetes mellitus.

View original record on NIH RePORTER →